Detalhe da pesquisa
1.
Correction to: Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
J Neuroinflammation
; 16(1): 119, 2019 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171009
2.
Enhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis.
J Neuroinflammation
; 15(1): 51, 2018 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467007
3.
ROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis.
Mol Cell Neurosci
; 74: 106-13, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27168379
4.
Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
J Neuroinflammation
; 13: 8, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757900
5.
Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis.
Mol Cell Neurosci
; 68: 284-92, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26311508
6.
Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.
J Neuroinflammation
; 12: 118, 2015 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26071315
7.
Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
Mol Cell Neurosci
; 56: 85-95, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23541702
8.
Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis.
Mol Immunol
; 94: 200-208, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331804
9.
Statins reduce the expressions of Tim-3 on NK cells and NKT cells in atherosclerosis.
Eur J Pharmacol
; 821: 49-56, 2018 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288118
10.
ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response.
J Neuroimmunol
; 311: 71-78, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844501
11.
Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
Neurosci Lett
; 656: 169-176, 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743581
12.
Parthenolide inhibits the initiation of experimental autoimmune neuritis.
J Neuroimmunol
; 305: 154-161, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28284336
13.
Activation of the adenosine A2A receptor exacerbates experimental autoimmune neuritis in Lewis rats in association with enhanced humoral immunity.
J Neuroimmunol
; 293: 129-136, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049573
14.
Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells.
Neurosci Lett
; 626: 25-34, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27181511
15.
Astilbin ameliorates experimental autoimmune myasthenia gravis by decreased Th17 cytokines and up-regulated T regulatory cells.
J Neuroimmunol
; 298: 138-45, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609287
16.
Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways.
J Neuroimmunol
; 281: 61-7, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25867469
17.
Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1(+) cells.
J Neuroimmunol
; 269(1-2): 28-37, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24565076
18.
Corrigendum to: "low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways" [Journal of Neuroimmunology 281 (2015) 61-67].
J Neuroimmunol
; 330: 181-183, 2019 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929679
19.
[Expressions of heat shock protein (HSP) family HSP 60, 70 and 90alpha in colorectal cancer tissues and their correlations to pathohistological characteristics].
Ai Zheng
; 28(6): 612-8, 2009 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-19635199